OPKO Health, Inc. Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory
OPKO Health, Inc. (OPK) had Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory of $148.90 million as of 2020-12-31, per its 10-K filed 2023-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory · last filed 2023-02-27
- 2020-12-31: Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory $148.90M.
| Period end | Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory |
|---|---|
| 2020-12-31 | $148.90M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |